Dialysis patients are more prone to COVID-19’s effects and consequences. COVID-19 was discovered in 35.3 percent of patients on maintenance dialysis, with 548 of the 1554 patients who participated in the study testing positive. Infection risk was three times higher in haemodialysis patients than in peritoneal dialysis patients (37 percent vs 11.3 percent ). 

More than half of those infected were admitted to the hospital (50.2 percent), and 24.5 percent were placed in an intensive care unit, where they died at a rate of 26.8 percent. In a recent study, researchers found that smoking and having a RH negative blood group were both linked to a higher mortality rate and were all found to be associated with an increased risk of death. 

Also, the prevalence of COVID-19 among Palestinian dialysis patients, particularly haemodialysis patients, was surprisingly high. COVID-19-related mortality was found to be a common event with hospitalization, ICU admission, intubation, and death. To reduce infection rates, strict infection control procedures and the promotion of home dialysis are required.

Words of importance

COVID-19 infection was common among Palestinian maintenance dialysis patients, with haemodialysis patients three times more likely to be infected than peritoneal dialysis patients.

This group had a staggering 26.7 percent death rate, which was more than 25 times the national norm. Having a central venous catheter for haemodialysis, as well as being older, male, smoking, and diabetic, increased mortality risk.

Advocating for home dialysis and strictly following infection control rules are both crucial to reducing illness transmission during dialysis procedures.

In the West Bank, 93.2 percent of dialysis patients were predicted to be on haemodialysis (HD), while 6.8 percent of the population was on peritoneal dialysis (PD). During the study period, 35.3 percent of the dialysis patients, or 548 patients, were infected with COVID-19. Only 11.3 percent of Parkinson’s disease patients were infected, but 37 percent of Huntington’s disease patients were.

The study involved 548 participants. Patients in this study ranged in age from 18 to 85, with a mean age of 60. Men made up 56.2 percent of the participants, while women made up 43.8 percent (23.4 percent ). Despite a range of 1 to 240 months, the median time spent on dialysis was 29 months. The vast majority of patients (97.8 percent) were on HD, with only a small minority (0.4 percent) on PD (2.2 percent ). In these cases, 366 patients (66.8 percent) had access to HD through a fistula.


The majority of people had hypertension as a comorbidity (63.9 percent). Diabetes was diagnosed in 59 percent of those polled. According to the study, more than a third of the patients had congestive heart failure (CHF), 25% had peripheral vascular disease (PVD), 8.8 percent had COPD, and 2.7 percent had cancer.

Nearly 90% of patients experienced at least one COVID-19-related symptom (fever was the most common, followed by dyspnea (56.2%), dry cough (42.1%), myalgic pain (42.1%), and anosmia (18.1%), in addition to a sore throat) (13.6 percent ). 11.3 percentage points (11.7 percent of total). Despite this, 11.3 percent of patients reported no symptoms.

Researchers discovered an unacceptably high prevalence of COVID-19 among Palestinian dialysis patients, with HD patients three times more likely to get the disease than PD patients. To reduce the risk of infection, strict infection control measures must be used, as well as home dialysis promotion. The fatality rate for infected dialysis patients was disturbingly high, according to the data. Male sex, CVC use, diabetes, smoking, and RH-negative blood group type were all associated with increased mortality risk in these persons.

Leave a Reply

Your email address will not be published.